[(2R,3R,4R,5R)-5-BROMO-3-(4-CHLOROBENZOYLOXY)-4-FLUORO-4-METHYLOXOLAN-2-YL]METHYL 4-CHLOROBENZOATE

Pharmaceutical intermediate

(2R,3R,4R,5R)-5-(2-amino-6-chloro-9H-purin-9-yl)-2-[(4-chlorobenzoyloxy)methyl]-4-fluoro-4-methyloxolan-3-yl 4-chlorobenzoate

pharmaceutical intermediate

(2R)-1-{5-Amino-2-[1-(benzyloxy)-2-methyl-2-propanyl]-6-fluoro-1H-indol-1-yl}-3-(benzyloxy)-2-propanol

pharmaceutical intermediate

Adenosine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-3'-O-[(1,1-dimethylethyl)dimethylsilyl]-, 2'-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite]

Pharmaceutical intermediate for oligonucleotide synthesis

(2R,3R)-2-[(benzoyloxy)methyl]-4,4-difluoro-5-oxooxolan-3-yl benzoate

pharmaceutical intermediate